Skip to main content
Clinical Trials/NCT04544085
NCT04544085UnknownNot Applicable

A Study on Noise Exposure Status and the Effect of Noise Management in Pediatric Intensive Care Unit

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1 site in 1 country204 target enrollmentStarted: July 16, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
204
Locations
1
Primary Endpoint
Delirium incidence

Study Overview

Brief Summary

This study has two stages. At the first stage,the investigators will try to use noise detectors to investigate the status of noise exposure in the pediatric intensive care unit(PICU) and to analyze the main noise sources in it. At the second stage,the investigators will try to evaluate the effect of noise management on noise exposure and health outcomes of the pediatric patients in PICU.The investigators hypothesize that noise exposure in PICU is higher than the standard.The investigators also hypothesize that the implementation of the noise management will improve the noise exposure and health outcomes of the pediatric patients in PICU.

Detailed Description

This study has two stages. At the first stage,the investigators will try to use noise detectors to investigate the status of noise exposure in the pediatric intensive care unit(PICU) and to analyze the main noise sources in it. At the second stage,the investigators will try to evaluate the effect of noise management on noise exposure and health outcomes of the pediatric patients in PICU.The investigators hypothesize that noise exposure in PICU is higher than the standard.The investigators also hypothesize that the implementation of the noise management will improve the noise exposure and health outcomes of the pediatric patients in PICU.

1.For the investigation of the status of noise exposure:

(1) Preparation of noise monitor equipment: select noise detectors conforming to the national standard. All noise detectors used in the study are of the same brand; (2) Use of noise monitor: set the mode of noise monitor according to the national standard: place the monitor in accordance with the requirements;(3) All the data of noise exposure will be collected and sorted out by the investigator. (4) Spss20.0 software is used for descriptive analysis and statistical inference. Mean ± standard deviation, median and quartile are used to describe measurement data, while frequency and percentage are used to describe counting data. Comparison between groups: when the measurement data obey normal distribution and the variance is homogeneous, two independent sample t-test are used to compare whether there is statistical difference between the two groups of indicators or index difference (measured value baseline value); if it does not obey normal distribution or the variance is uneven, non parametric statistical method is used; counting data: Chi square test is used to compare whether there is statistical difference between the two groups of index values, test level: α = 0.05 2.For the evaluation of the effect of noise management on noise exposure and health outcomes of the pediatric patients in PICU:

(1)General information and clinical data of patients will be collected through hospital electronic information system, ICU nursing records, cases, doctor's advice and consultation. The investigator will evaluate and record the delirium score of ICU children who met the inclusion criteria each shift . At the time of discharge, PICU duration, hospital stay, MV duration and in-hospital mortality were inquired by EMR. (2) Quality control of intervention implementation are as follows:① According to the research results of early promotion strategy, relevant training materials were made to carry out training and education for PICU medical staff;② During the implementation of the intervention, irregular sampling of medical staff was conducted to evaluate the implementation of the intervention and give timely feedback.(3) Collection of information:① The data of patients will be collected by the investigator;② Pediatric delirium score: in order to ensure the quality of the study, the investigator will conduct random sampling and assess the delirium of children in the same patient with the nurses from time to time to investigate the evaluation quality;③ Input the data into EpiData, set reasonable numerical boundary value and logical check items. If there is logical error, check the original data for correction, and import the data into spss20.0 for statistical analysis.

(4) Sample size assessment: the assessment of sample size in experimental research can also be divided into measurement data and counting data. The main outcome measures are delirium rate and noise exposure. Therefore, the incidence of delirium will be used as the rate to calculate the sample size.According to the calculation formula of the rate: n = (U α + U β) 22P (1-p) / (P1-P2) 2, the sample size of the control group and the intervention group are calculated. Uα=1.64,Uβ=0.84。P1 and P2 are the estimated values of delirium incidence before and after the intervention, and P is the total rate. The references showed that P1 = 33%, P2 = 14%.The sample size calculated by the formula is: (1.64 + 0.84) 2 * 2 * 0.47 * 0.53 / 0.192 = 85 cases, plus 20% of the sample loss, that is, 102 cases in the control group and 102 cases in the intervention group (5)Statistical Analysis:①Data set: use EpiData 3.1 software to establish the data set, and clean up and check the data;② The data will be imported into spss20.0 for statistical analysis. Descriptive analysis and statistical inference will be carried out. Mean ± standard deviation, median and quartile are used to describe measurement data, while frequency and percentage are used to describe counting data. Comparison between groups: when the measurement data obeys normal distribution and the variance is homogeneous, two independent sample t-test is used to compare whether there is statistical difference in the indicators or index difference (measured value baseline value) between the two groups; if the measurement data does not obey the normal distribution or the variance is uneven, non parametric statistical method is used; counting data: Chi square test is used to compare whether there is statistical difference between the two groups of patients Level: α = 0.05.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients aged ≤ 18 years
  • •The predicted PICU LOS ≥12 hours
  • •The informed consent of the child's guardian was obtained

Exclusion Criteria

  • •Patients with delirium on admission
  • •Patients in a coma (Richmond Agitation Sedation Scale[RASS]-4 or -5) all through their stay in PICU
  • •Patients with mental disorders or mental retardation, who continue to use antipsychotic drugs
  • •Patients undergoing neurosurgery and neurology surgery
  • •Hearing or visual impairment
  • •Non Chinese or English language users
  • •Missed or incomplete delirium score

Arms & Interventions

control group

No Intervention

Patients in the control group will not receive any noise management intervention

experimental group

Experimental

Patients in the experimental group will receive noise management. The intervention measures mainly include the following three parts: control of noise source, control of noise transmission and personal protection of noise receiver.We will strengthen the education of medical staff to ensure the effective implementation of the noise management.

Intervention: noise management (Behavioral)

Outcomes

Primary Outcomes

Delirium incidence

Time Frame: Up to 1 month

Delirium screening is performed using the Cornell assessment of pediatric delirium(CAPD).Delirium will be screened every 12 hours(at 8:00a.m.\&20:00p.m.) until the patient is transferred out of PICU or drops out

Noise exposure

Time Frame: Average of 1 weak

Noise is measured in decibels.The noise exposure in PICU will be described in Leq,Lmax,Lmin

Secondary Outcomes

  • Duration of mechanical ventilation(MV)(60 days after the enrollment)
  • Medical staff's knowledge of noise management(1 hour within the end of the lecture on noise management for medical staff)
  • PICU length of stay(LOS)(60 days after the enrollment)
  • Hospital length of stay(LOS)(60 days after the enrollment)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Phase 1
A Study of Tetrathiomolybdate (TM) Plus CapecitabineResidual DiseaseTriple Negative Breast Cancer
NCT06134375Dartmouth-Hitchcock Medical Center204
Active, not recruiting
Phase 1
Clinical study to investigate the activity and safety of anti-PD-L1 antibody (Durvalumab) in patients with advanced malignant pleural mesothelioma after a previous therapyAdvanced malignant pleural mesotheliomaMedDRA version: 20.0Level: PTClassification code 10027406Term: MesotheliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2016-000617-67-ITIRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI57
Active, not recruiting
Not Applicable
Phase II trial assessing the impact on instrumental and daily living autonomy of a chemotherapy regimen with bi-weekly docetaxel in the treatment of metastatic breast cancer in patients over the age of 70 - Bi-weekly docetaxelHR+ or HR- metastatic adenocarcinoma of the breast with a measurable target (RECIST criteria) in patients aged 70 or overMedDRA version: V5Level: LLTClassification code 10027475
EUCTR2004-002839-10-GBFédération Nationale des Centres de Lutte Contre le Cancer58
Active, not recruiting
Not Applicable
Phase II trial assessing the impact on instrumental and daily living autonomy of chemotherapy with bi-weekly docetaxel in the treatment of metastatic or locally advanced non-small cell lung cancer in patients over the age of 70. - bi-weekly docetaxel-NSCLCElderly patients form an increasing proportion of the lung cancer population. The median age of patients with a bronchial cancer is 68 years old (Gridelli et al., 1997). In a more recent study, Ng et al. (2004) showed that 46% of patients are over the age of 70 when the NSCLC is diagnosed. Around 37% of patients aged over 70 are not treated, in contrast with younger patients.MedDRA version: V5Level: LLTClassification code 10029514
EUCTR2005-000068-23-GBFédération Nationale des Centres de Lutte Contre le Cancer60
Completed
Phase 1
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or ObesityOverweightObesity
NCT06478563Novo Nordisk A/S133